I know you don't use the news but with SAVA dropping the drug after failing phase 3 and nothing else in the pipeline why would the price rise? Also I see the vultures are flying overhead with a few class action suites being filed that will eat up some cash with legal costs. I hope you are not throwing good money after bad by averaging down. Good luck!!
hindenburgreserch.com/renovaro/ Has an article that maybe can serve as a case studie. The article is titled *Renovaro BioSciences A Worthless AI Shell Game With A Murderous Magician Past* Stock Ticker RENB I do not know the arvarge time for class actions/law suit in the US But, the article is funny reading. That said, when the stock falled to 40cent it raised to 4 dollar, and then falled to 40cent again. When you look at a chart, and file it in you heart, then it is now. As looking at a nice girl, file it in the heart, look at chart. Then you know what to do, and only you. No dued should tell you to all out or all in. You file it your heart
Hey I should join the class action! https://www.accesswire.com/947139/b...c-sava-and-encourages-stockholders-to-connect
Sometime tonight I should finally sign up or TD's class action as well. That's what I get for owning part of FIAT banks.
Saylor/MSTR/Bitcoin's smartest critic posts another video attacking the CEO. And refers to him as a 2x fraudster.
My current positions on MSTR are: DEC 6 +310C/-330C DEC 13 +360C/-370C DEC 20 +300C/-325C I like to roll/ladder/leapfrog, what ever you like to call it. So far, so good. So this week I hope to to roll the DEC 6 position into the DEC 27 +310C/-330C for a good premium. As of this moment it's a credit of +$482.00
Marathon has also been copying MSTR's strategy with their zero-coupon convertible senior notes. To be matured in 2030. They were able to pay down a lot of expensive debt, so it's worked out very well for them. Unfortunately, retail is still not allowed to trade any.